Patents by Inventor Meital Cohen

Meital Cohen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS AND USES THEREOF
    Publication number: 20230346805
    Abstract: The present disclosure relates to compositions, including foamable compositions with improved properties, such as those comprising waxes, emollients, foam adjuvants and/or active agents, and methods for preparing and using them.
    Type: Application
    Filed: July 30, 2020
    Publication date: November 2, 2023
    Inventors: Iain Stuart, Flor De Maria Alvarez Mitre, Russell Elliott, Gary Lawrence, Meital Cohen-Asis, Anat London-Drori, Yohan Hazot, Ariel Margulis
  • Solid state forms of ibrutinib
    Patent number: 10035802
    Abstract: The present invention encompasses solid state forms of Ibrutinib, including forms G, J and K, and pharmaceutical compositions thereof.
    Type: Grant
    Filed: August 13, 2015
    Date of Patent: July 31, 2018
    Assignee: TEVA PHARMACEUTICALS USA, INC.
    Inventors: Meital Cohen, Yuval Cohen, Ariel Mittelman, Elana Ben Moha-Lerman, Idit Tzanani, Leonid Levenfeld
  • SOLID STATE FORMS OF IBRUTINIB
    Publication number: 20170226114
    Abstract: The present invention encompasses solid state forms of Ibrutinib, including forms G, J and K, and pharmaceutical compositions thereof.
    Type: Application
    Filed: August 13, 2015
    Publication date: August 10, 2017
    Inventors: Meital Cohen, Yuval Cohen, Ariel Mittelman, Elana Ben Moha-Lerman, Idit Tzanani, Leonid Levenfeld
  • Processes for the preparation and purification of gabapentin enacarbil
    Patent number: 8283487
    Abstract: Gabapentin enacarbil was prepared and purified from intermediates such as 1-haloalkyl carbamate or carbonate and diacid acetal skeleton. For example, a 1-haloalkyl carbonate or carbamate was prepared by combining a C1 to C10 alcohol or C1 to C10 primary amine, a solvent selected from the group consisting of: acetonitrile, C3 to C7 ketone, C5 to C10 ether, C2 to C7 ester, C5 to C10 hydrocarbon and a combination thereof; a 1-haloalkyl haloformate of the following formula: wherein each X is independently selected from Br, I, or Cl; R1 is alkyl or H; and a C6 to C21 tertiary amine.
    Type: Grant
    Filed: November 26, 2009
    Date of Patent: October 9, 2012
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Elena Ben Moha-Lerman, Tamar Nidam, Meital Cohen, Sharon Avhar-Maydan, Anna Balanov
  • PROCESSES FOR THE PREPARATION AND PURIFICATION OF GABAPENTIN ENACARBIL
    Publication number: 20100160665
    Abstract: Gabapentin enacarbil was prepared and purified from intermediates such as 1-haloalkyl carbamate or carbonate and diacid acetal skeleton. For example, a 1-haloalkyl carbonate or carbamate was prepared by combining a C1 to C10 alcohol or C1 to C10 primary amine, a solvent selected from the group consisting of: acetonitrile, C3 to C7 ketone, C5 to C10 ether, C2 to C7 ester, C5 to C10 hydrocarbon and a combination thereof; a 1-haloalkyl haloformate of the following formula: wherein each X is independently selected from Br, I, or Cl; R1 is alkyl or H; and a C6 to C21 tertiary amine.
    Type: Application
    Filed: November 26, 2009
    Publication date: June 24, 2010
    Applicant: TEVA PHARMACEUTICAL INDUSTRIES LTD.
    Inventors: Elena Ben Moha-Lerman, Tamar Nidam, Meital Cohen, Sharon Avhar-Maydan, Anna Balanov
  • GABAPENTIN ENACARBIL SALTS AND PROCESSES FOR THEIR PREPARATION
    Publication number: 20100004485
    Abstract: The preparation and use of calcium, barium, magnesium and copper salts of gabapentin enacarbil are described.
    Type: Application
    Filed: July 2, 2009
    Publication date: January 7, 2010
    Applicant: TEVA PHARMACEUTICAL INDUSTRIES LTD.
    Inventors: Meital COHEN, Valerie NIDDAM-HILDESHEIM, Maytal PIRAN, Elena BEN MOHA-LERMAN